News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioMidwest
Hitachi Medical Systems America Exhibits 64-slice SCENARIA with Advanced Dose Reduction Technology at Radiological Society of North America (RSNA)
November 21, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CLEVELAND--(BUSINESS WIRE)--Hitachi’s 64-slice SCENARIA is now in worldwide clinical use, where it is proving itself as an excellent lower dose* and optimum value clinical platform for both routine and advanced applications.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
February 13, 2026
·
6 min read
·
Heather McKenzie
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
February 11, 2026
·
4 min read
·
Heather McKenzie
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
·
6 min read
·
Heather McKenzie